Approvals/TGA/APO-AGOMELATINE agomelatine (as agomelatine-citric acid) 25 mg film-coated tablet blister pack

Approved

STANDARD

APO-AGOMELATINE agomelatine (as agomelatine-citric acid) 25 mg film-coated tablet blister pack

Southern Cross Pharma Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: f40438419dfc942f
Product Name: APO-AGOMELATINE agomelatine (as agomelatine-citric acid) 25 mg film-coated tablet blister pack
Artg Id: 318686
Artg Name: APO-AGOMELATINE agomelatine (as agomelatine-citric acid) 25 mg film-coated tablet blister pack
Sponsor: Southern Cross Pharma Pty Ltd
Company Detail Path: /organization/southern-cross-pharma-pty-ltd
Artg Date: 2020-06-26
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

f40438419dfc942f

Type

Standard